EP 3856195 A1 20210804 - METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS USING CCR3-INHIBITORS
Title (en)
METHODS AND COMPOSITIONS FOR TREATING AGING-ASSOCIATED IMPAIRMENTS USING CCR3-INHIBITORS
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON ALTERUNGSASSOZIIERTEN STÖRUNGEN UNTER VERWENDUNG VON CCR3-INHIBITOREN
Title (fr)
PROCÉDÉS ET COMPOSITIONS POUR TRAITER DES TROUBLES LIÉS AU VIEILLISSEMENT AU MOYEN D'INHIBITEURS DE CCR3
Publication
Application
Priority
- US 201862737017 P 20180926
- US 2019052995 W 20190925
Abstract (en)
[origin: WO2020069008A1] Methods of improving neurodegenerative disease with CCR3 modulating agents are provided. The methods include administering a therapeutically effective amount of the CCR3 modulating agent to the subject, with a concomitant improvement in cognition, motor, or other neurodegenerative-affected function. Cognitive and motor diseases upon which the methods of the invention can improve cognition include Alzheimer's disease, Parkinson's disease, frontotemporal dementia, Huntington's disease, amyotrophic lateral sclerosis, multiple sclerosis, glaucoma, myotonic dystrophy, vascular dementia, progressive supranuclear palsy.
IPC 8 full level
A61K 31/535 (2006.01); A61K 31/445 (2006.01); C07D 401/04 (2006.01); C07D 413/02 (2006.01)
CPC (source: EP IL KR)
A61K 31/4545 (2013.01 - EP IL KR); A61K 45/06 (2013.01 - EP IL); A61K 47/02 (2013.01 - KR); A61K 47/26 (2013.01 - KR); A61K 47/38 (2013.01 - KR); A61P 1/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/28 (2017.12 - KR); C07D 401/14 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2020069008 A1 20200402; AU 2019346456 A1 20210415; BR 112021004938 A2 20210601; CA 3111433 A1 20200402; CL 2021000724 A1 20211015; CN 112789044 A 20210511; CO 2021003713 A2 20210408; EA 202190463 A1 20210629; EP 3856195 A1 20210804; EP 3856195 A4 20220622; IL 281578 A 20210531; JP 2022502441 A 20220111; KR 20210065950 A 20210604; MA 53743 A 20220105; MX 2021002967 A 20210811; SG 11202102105V A 20210429; TW 202027752 A 20200801
DOCDB simple family (application)
US 2019052995 W 20190925; AU 2019346456 A 20190925; BR 112021004938 A 20190925; CA 3111433 A 20190925; CL 2021000724 A 20210323; CN 201980063258 A 20190925; CO 2021003713 A 20210324; EA 202190463 A 20190925; EP 19867321 A 20190925; IL 28157821 A 20210317; JP 2021517342 A 20190925; KR 20217008493 A 20190925; MA 53743 A 20190925; MX 2021002967 A 20190925; SG 11202102105V A 20190925; TW 108134938 A 20190926